Clinical Trials
All Clinical Trials - Page 4 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07679516N/ANot Yet Recruiting
Postprandial Regulation of Bone Perfusion in Healthy Individuals
Pramlintide
- NCT07738276Phase 3Not Yet Recruiting
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
Tirzepatide
- NCT07613307Phase 3Recruiting
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Orforglipron
- NCT07835360N/ARecruiting
Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes
Tirzepatide
- NCT06820281Phase 2Recruiting
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Tirzepatide
- NCT07662213Phase 3Recruiting
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Semaglutide
- NCT07531251Phase 4Recruiting
Clinical Trial in Patients With Barth Syndrome- 4TAZPower
Elamipretide
- NCT07635953Phase 3Not Yet Recruiting
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
Tirzepatide
- NCT07636239N/ANot Yet Recruiting
Eating Behavior, Nutritional Status and Appetite Hormones After Bariatric Surgery
Ghrp-6
- NCT07403604Phase 1Recruiting
Effect of Insulin Lowering on Lipogenesis
Octreotide
- NCT07537686Phase 2Not Yet Recruiting
Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED)
Teduglutide
- NCT07720414N/ARecruiting
Effects of GLP-1 RAs on Human Lactation Outcomes
Tirzepatide
- NCT07706088Phase 4Not Yet Recruiting
Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy
Tirzepatide
- NCT07700030N/ANot Yet Recruiting
High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)
Tirzepatide
- NCT07727473EARLY_Phase 1Not Yet Recruiting
Preoperative Semaglutide Prior to Radical Prostatectomy
Semaglutide
- NCT07457164Phase 2Not Yet Recruiting
A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer
Gonadorelin
- NCT07654062Phase 4Not Yet Recruiting
Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
Mazdutide
- NCT07866183N/ARecruiting
Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative Study
Tirzepatide
- NCT07707778Phase 4Enrolling By Invitation
Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV
Tirzepatide
- NCT07663318Phase 1Completed
A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)
Octreotide
- NCT07357766Phase 3Withdrawn
A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
Semaglutide
- NCT07587775Phase 2Enrolling By Invitation
The Effect of Osteoporotic Medications on Vertebral Bone Quality Score
Abaloparatide
- NCT07382024N/ANot Yet Recruiting
Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
Tirzepatide
- NCT07021937Phase 3Not Yet Recruiting
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
Semaglutide
- NCT07702461N/ARecruiting
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
Tirzepatide
- NCT07046819Phase 2Recruiting
Tirzepatide in MetALD
Tirzepatide
- NCT07517042N/ARecruiting
ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
Mazdutide
- NCT07257484Phase 4Recruiting
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Tirzepatide
- NCT07602699Phase 2Recruiting
Multi-Site Trial of Tirzepatide for Smoking Cessation
Tirzepatide
- NCT07583563N/ARecruiting
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
Octreotide
- NCT06726577Phase 1/Phase 2Recruiting
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Liraglutide
- NCT07712328Phase 4Enrolling By Invitation
Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors
Desmopressin
- NCT07605247Phase 2Not Yet Recruiting
Tirzepatide in the Treatment of Endometrial Cancer
Tirzepatide
- NCT07444073N/ANot Yet Recruiting
Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock
Tirzepatide
- NCT07570810N/ANot Yet Recruiting
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM
Semaglutide
- NCT07443826Phase 1/Phase 2Recruiting
CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy
Follistatin
- NCT07569315Phase 2Not Yet Recruiting
Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders
Gonadorelin
- NCT07642700N/ANot Yet Recruiting
GnRH Agonist Pretreatment in Persistent Chronic Endometritis Undergoing FET
Gonadorelin
- NCT07282769Phase 2Not Yet Recruiting
Semaglutide (Wegovy) Treatment for Trichotillomania
Semaglutide
- NCT06824818N/ARecruiting
Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
Gonadorelin
- NCT07623824Phase 3Not Yet Recruiting
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly
Octreotide
- NCT07858864N/ARecruiting
GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes
Tirzepatide
- NCT07607587Phase 1Recruiting
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Cagrilintide
- NCT07650149N/ARecruiting
Genetic, Microbiological and Behavioral Factors in Obesity
Tirzepatide
- NCT07527910Phase 2Recruiting
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Tirzepatide
- NCT07564414Phase 3Recruiting
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Semaglutide
- NCT07559500Phase 1Recruiting
Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
Tirzepatide
- NCT07605052Phase 1Completed
A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
Cagrilintide
- NCT07400107Phase 3Not Yet Recruiting
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Semaglutide
- NCT07284511Phase 2/Phase 3Recruiting
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Tirzepatide